Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

S. Gillessen · SciRah

Researcher profile · Semantic Scholar

S. Gillessen

Share profile

S. Gillessen — researcher profile on SciRah

h-index: 80
Works: 499
Citations: 32K

Most-cited papers

ESMO Clinical Practice Guideline interim update on first-line therapy in advanced urothelial carcinoma.
T. Powles, J. Bellmunt, E. Compérat, M. De Santis +9 more
2024Annals of Oncology177 citations
Semantic Scholar
Management of Patients with Advanced Prostate Cancer. Report from the 2024 Advanced Prostate Cancer Consensus Conference (APCCC).
S. Gillessen, F. Turco, Ian D. Davis, J. Efstathiou +117 more
2024European Urology142 citations Open access
Semantic Scholar
Enzalutamide plus radium-223 in metastatic castration-resistant prostate cancer: results of the EORTC 1333/PEACE-3 trial.
B. Tombal, A. Choudhury, F. Saad, E. Gallardo +21 more
2025Annals of Oncology53 citations Open access
Semantic Scholar
Penile cancer: ESMO–EURACAN Clinical Practice Guideline for diagnosis, treatment and follow-up
A. Muneer, M. Bandini, E. Compérat, G. De Meerleer +7 more
2024ESMO Open46 citations Open access
Semantic Scholar
Combination Therapies in Locally Advanced and Metastatic Hormone-sensitive Prostate Cancer.
A. Azad, Louise Kostos, Neeraj Agarwal, G. Attard +8 more
2025European Urology41 citations Open access
Semantic Scholar
Heterogeneity of Treatment Effect with PARP Inhibitors in Metastatic Castration-resistant Prostate Cancer: A Living Interactive Systematic Review and Meta-Analysis
S. Naqvi, I. Bin Riaz, A. Bibi, Muhammad Ali Khan +17 more
2025European Urology39 citations Open access
Semantic Scholar
SPARC: The Standardised Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Analysis and Reporting Consensus: A Delphi Analysis.
K. Herrmann, J. Walz, S. Maclennan, A. Briganti +27 more
2025European Urology37 citations Open access
Semantic Scholar
LBA1 A randomized multicenter open label phase III trial comparing enzalutamide vs a combination of Radium-223 (Ra223) and enzalutamide in asymptomatic or mildly symptomatic patients with bone metastatic castration-resistant prostate cancer (mCRPC): First results of EORTC-GUCG 1333/PEACE-3
S. Gillessen, A. Choudhury, F. Saad, E. Gallardo +14 more
2024Annals of Oncology37 citations
Semantic Scholar
Decrease in Fracture Rate with Mandatory Bone-protecting Agents in the EORTC 1333/PEACE-3 Trial Comparing Radium-223 Combined with Enzalutamide Versus Enzalutamide Alone: A Safety Analysis.
S. Gillessen, Bertrand F. Tombal, F. Turco, Ananya Choudhury +20 more
2025European Urology36 citations Open access
Semantic Scholar
Neoadjuvant and Adjuvant Immune-based Approach for Renal Cell Carcinoma: Pros, Cons, and Future Directions.
L. Marandino, R. Campi, D. Amparore, Z. Tippu +13 more
2024European Urology Oncology36 citations Open access
Semantic Scholar
Tumor transcriptome-wide expression classifiers predict treatment sensitivity in advanced prostate cancers.
E. Grist, P. Dutey-Magni, Marina A. Parry, L. Mendes +43 more
2025Cell34 citations Open access
Semantic Scholar
Androgen receptor pathway inhibitors and drug–drug interactions in prostate cancer
H. Bolek, S. C. Yazgan, E. Yekedüz, M. Kaymakcalan +3 more
2024ESMO Open34 citations Open access
Semantic Scholar
Delphi consensus on stereotactic ablative radiotherapy for oligometastatic and oligoprogressive renal cell carcinoma-a European Society for Radiotherapy and Oncology study endorsed by the European Association of Urology.
G. Marvaso, B. Jereczek-Fossa, M. Zaffaroni, M. Vincini +36 more
2024The Lancet Oncology33 citations Open access
Semantic Scholar
Advanced and metastatic prostate cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.
K. Fizazi, G. Attard, A. Azad, G. Baciarello +29 more
2026Annals of Oncology30 citations Open access
Semantic Scholar
External validation of a digital pathology-based multimodal artificial intelligence-derived prognostic model in patients with advanced prostate cancer starting long-term androgen deprivation therapy: a post-hoc ancillary biomarker study of four phase 3 randomised controlled trials of the STAMPEDE pl
C. Parker, L. Mendes, V. Liu, E. Grist +36 more
2025The Lancet Digital Health28 citations Open access
Semantic Scholar
Prognostic and Predictive Role of SPOP Mutations in Prostate Cancer: A Systematic Review and Meta-analysis.
Martino Pedrani, G. Salfi, S. Merler, Irene Testi +10 more
2024European Urology Oncology24 citations Open access
Semantic Scholar
Prostate-specific Antigen Response as a Prognostic Factor for Overall Survival in Patients with Prostate Cancer Treated with Androgen Receptor Pathway Inhibitors: A Systematic Review and Meta-analysis.
Marcin Miszczyk, T. Fazekas, P. Rajwa, A. Matsukawa +10 more
2025European Urology Focus23 citations Open access
Semantic Scholar
EORTC 2238 “De-Escalate”: a pragmatic trial to revisit intermittent androgen deprivation therapy in the era of new androgen receptor pathway inhibitors
G. Grisay, F. Turco, S. Litière, B. Fournier +6 more
2024Frontiers in Oncology22 citations Open access
Semantic Scholar
Metformin for patients with metastatic prostate cancer starting androgen deprivation therapy: a randomised phase 3 trial of the STAMPEDE platform protocol
S. Gillessen, Laura R. Murphy, N. James, A. Sachdeva +49 more
2025The Lancet Oncology21 citations Open access
Semantic Scholar
Coagulation factor X promotes resistance to androgen-deprivation therapy in prostate cancer.
B. Calí, M. Troiani, S. Bressan, Giuseppe Attanasio +41 more
2024Cancer Cell17 citations Open access
Semantic Scholar
EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer-2026 Update. Part I: Screening, Diagnosis, and Local Treatment with Curative Intent.
P. Cornford, R. V. D. van den Bergh, E. Briers, Peter K. F. Chiu +23 more
2026European Urology16 citations
Semantic Scholar
The Emerging Predictive and Prognostic Role of Aggressive-Variant-Associated Tumor Suppressor Genes Across Prostate Cancer Stages
Martino Pedrani, J. Barizzi, G. Salfi, A. Nepote +9 more
2025International Journal of Molecular Sciences16 citations
Semantic Scholar
Which patients with metastatic hormone-sensitive prostate cancer (mHSPC) benefit more from androgen receptor pathway inhibitors (ARPIs)? STOPCAP meta-analyses of individual participant data (IPD).
D. Fisher, C. Vale, L. Rydzewska, P. Godolphin +15 more
2025Journal of Clinical Oncology14 citations
Semantic Scholar
EORTC GUCG 2238 De-escalate: A pragmatic trial to revisit intermittent androgen-deprivation therapy in metastatic hormone-naïve prostate cancer in the era of new AR pathway inhibitors.
G. Grisay, F. Turco, A. Patrikidou, Enrique Gallardo Díaz +5 more
2024Journal of Clinical Oncology14 citations
Semantic Scholar
Local and locoregional prostate cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.
J. Walz, G. Attard, A. Bjartell, P. Blanchard +22 more
2025Annals of Oncology13 citations Open access
Semantic Scholar
Prognostic Impact of Prostate-Specific Antigen at 6 Months After Radiotherapy in Localized Prostate Cancer: An Individual Patient Data Analysis of Randomized Trials
L. Kwak, P. Ravi, John G. Armstrong, V. Beckendorf +15 more
2024Journal of Clinical Oncology13 citations Open access
Semantic Scholar
Refining Risk-Stratification of High-Risk and Locoregional Prostate Cancer: A Pooled Analysis of Randomized Trials
P. Ravi, Wan-Ling Xie, M. Buyse, S. Halabi +16 more
2024European Urology13 citations Open access
Semantic Scholar
Final overall survival results from EORTC 1333/PEACE-3 trial of enzalutamide plus radium-223 in metastatic castration-resistant prostate cancer.
S. Gillessen, E. Gallardo, A. Choudhury, F. Saad +21 more
2026Annals of Oncology11 citations Open access
Semantic Scholar
EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer. Part II-2026 Update: Treatment of Relapsing and Metastatic Prostate Cancer.
D. Tilki, R. V. D. van den Bergh, E. Briers, Peter K. F. Chiu +23 more
2026European Urology11 citations
Semantic Scholar
1596O Decipher mRNA score for prediction of survival benefit from docetaxel at start of androgen deprivation therapy (ADT) for advanced prostate cancer (PC): An ancillary study of the STAMPEDE docetaxel trials
E. Grist, P. Dutey-Magni, L. Mendes, M. Parry +16 more
2024Annals of Oncology11 citations Open access
Semantic Scholar
Multi-institutional Analysis of Metastasis-directed Therapy with or Without Androgen Deprivation Therapy in Oligometastatic Castration-sensitive Prostate Cancer.
M. Deek, P. Sutera, Yue-Zhou Jing, Robert W. Gao +26 more
2024European Urology Oncology11 citations
Semantic Scholar
Treatment Landscape of Prostate Cancer in the Era of PSMA Radiopharmaceutical Therapy
F. Turco, S. Gillessen, Ken Herrmann, Gaetano Paone +1 more
2025Journal of Nuclear Medicine10 citations Open access
Semantic Scholar
Transdermal Estradiol Patches in Locally Advanced Prostate Cancer.
Ruth Langley, D. Gilbert, S. Mangar, Stuart Rosen +48 more
2026New England Journal of Medicine9 citations
Semantic Scholar
Comparative survival in metastatic hormone sensitive prostate cancer by volume of disease and timing of metastasis: a living network meta-analysis
I. Bin Riaz, Syed Arsalan Ahmed Naqvi, Kunwer Sufyan Faisal, Huan He +23 more
2025European Urology7 citations Open access
Semantic Scholar
Is There a Place for De-escalating Therapy in Patients with Metastatic Hormone-sensitive Prostate Cancer?
F. Turco, Bertrand F. Tombal, S. Gillessen, A. Omlin
2024European Urology Focus7 citations
Semantic Scholar
Integrating Aggressive-Variant Prostate Cancer-Associated Tumor Suppressor Gene Status with Clinical Variables to Refine Prognosis and Predict Androgen Receptor Pathway Inhibitor Response in Metastatic Hormone-Sensitive Setting
Martino Pedrani, G. Salfi, S. Merler, Irene Testi +10 more
2025International Journal of Molecular Sciences6 citations Open access
Semantic Scholar
The Co-IMPACT Consortium: Integrating Prostate-specific Membrane Antigen Positron Emission Tomography and Radiotherapy in Prostate Cancer Care.
V. Murthy, G. Marvaso, B. Jereczek-Fossa, Stephanie A. Thoma +14 more
2025European Urology6 citations
Semantic Scholar
oDigital pathology biomarkers for guiding radiotherapy-based treatment concepts in prostate cancer - a systematic review and expert consensus.
Constantinos Zamboglou, W. De Doncker, A. Christoforou, S. Arcangeli +54 more
2025Radiotherapy and Oncology6 citations Open access
Semantic Scholar
ESUR: Opportunities for PSMA-PET/CT and whole-body MRI in advanced prostate cancer
Sung-Min Woo, L. Russo, Sam J. Withey, Ailin Dehghanpour +15 more
2025European Radiology6 citations Open access
Semantic Scholar
Antiandrogens as Therapies for COVID-19: A Systematic Review
Massimiliano Cani, Samantha Epistolio, Giulia Dazio, Mikol Modesti +10 more
2024Cancers6 citations Open access
Semantic Scholar
Activity of Lutetium-177 Prostate-specific Membrane Antigen and Determinants of Outcomes in Patients with Metastatic Castration-resistant Prostate Cancer Previously Treated with Cabazitaxel: The PACAP Study.
R. Flippot, T. Telli, M. Velev, A. Fléchon +25 more
2024European Urology Oncology6 citations
Semantic Scholar
Clinical trial endpoints for metastases-directed therapy in oligometastatic cancer: a review and Delphi consensus on behalf of the EORTC-ESTRO OligoCare consortium.
Joachim Widder, G. Bol, I. Simek, F. Ehret +34 more
2026The Lancet Oncology5 citations Open access
Semantic Scholar
On-treatment serum prostate-specific antigen and overall survival in prostate cancer (STAMPEDE platform protocol): a post-hoc analysis of data from five phase 3 trials.
M. Kayani, Laura R. Murphy, P. Dutey-Magni, Sarah Howlett +22 more
2026The Lancet Oncology5 citations Open access
Semantic Scholar
Prostate Cancer Foundation White Paper on Combination Therapy for Metastatic Hormone-Sensitive Prostate Cancer.
Sigrid V. Carlsson, Pedro C. Barata, Alan H. Bryce, Daniel J. George +24 more
2025JCO Oncology Practice5 citations Open access
Semantic Scholar
Risk of bone fractures in patients with prostate cancer treated with maximal androgen blockade therapy: a systematic literature review and meta-analysis
I. Saporita, Mariangela Calabrese, F. Carfì, Andrea Mogavero +15 more
2026Prostate Cancer and Prostatic Diseases4 citations Open access
Semantic Scholar
Enzalutamide Plus Metformin Versus Enzalutamide Alone in Metastatic Castration-resistant Prostate Cancer: A Randomized Phase 2 Trial (SAKK 08/14).
S. Gillessen, K. Gobat, R. Cathomas, N. Fischer +25 more
2026European Urology Oncology4 citations Open access
Semantic Scholar
Activity of Platinum Monotherapy in Patients With Metastatic Castration-Resistant Prostate Cancer and DNA Damage Repair Gene Alterations.
M. Aldea, Émeline Orillard, A. Bernard-Tessier, L. Cerbone +18 more
2025JCO Precision Oncology4 citations
Semantic Scholar
Maximal androgen blockade therapy (MAB) for prostate cancer (PC) and risk of bone fractures: A systematic literature review and meta-analysis.
F. Turco, I. Saporita, Mariangela Calabrese, F. Carfì +7 more
2024Journal of Clinical Oncology4 citations Open access
Semantic Scholar
Final overall survival results from the EORTC 1333/PEACE-3 trial: Enzalutamide with or without radium-223 in metastatic castration-resistant prostate cancer.
E. Gallardo, Bertrand F. Tombal, A. Choudhury, Fred Saad +14 more
2026Journal of Clinical Oncology3 citations Open access
Semantic Scholar
2420MO Effects of prostate radiotherapy (RT) on synchronous, metastatic, hormone-sensitive prostate cancer (mHSPC): STOPCAP meta-analysis of individual participant data (IPD)
P. J. Godolphin, S. Burdett, A. Sachdeva, L. Rydzewska +16 more
2025Annals of Oncology3 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

Bertrand F. Tombal×11
Invite
Bertrand F. Tombal — researcher profile on SciRah
F. Turco×9
Invite
F. Turco — researcher profile on SciRah
G. Attard×8
Invite
G. Attard — researcher profile on SciRah
M. Sydes×7
Invite
M. Sydes — researcher profile on SciRah

×6

Invite

T. Zilli — researcher profile on SciRah

Invite

F. Lecouvet — researcher profile on SciRah

Invite

A. Sachdeva — researcher profile on SciRah

Invite

U. Vogl — researcher profile on SciRah

Invite

F. Turco — researcher profile on SciRah

Invite

Y. Loriot — researcher profile on SciRah

Invite

K. Fizazi — researcher profile on SciRah

Invite

D. Matheson — researcher profile on SciRah